Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer

NCT06184698 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

173

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: liposomal irinotecan
DRUG: 5-FU
DRUG: LV
DRUG: Bevacizumab

Sponsor

Hebei Medical University Fourth Hospital